Page last updated: 2024-08-17

carbostyril and Leukemia, Monocytic, Acute

carbostyril has been researched along with Leukemia, Monocytic, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creutzig, U; Gibson, BE; Goemans, BF; Hählen, K; Harlow, A; Heinrich, MC; Kaspers, GJ; Loonen, AH; Reinhardt, D; Zwaan, CM1

Other Studies

1 other study(ies) available for carbostyril and Leukemia, Monocytic, Acute

ArticleYear
In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets.
    Blood, 2005, Nov-15, Volume: 106, Issue:10

    Topics: Adolescent; Antineoplastic Agents; Biomarkers, Tumor; Child; Child, Preschool; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Farnesyltranstransferase; Female; Humans; Leukemia, Monocytic, Acute; Male; Mutation; Oncogene Protein p21(ras); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinolones; Tumor Cells, Cultured

2005